Raludotatug Deruxtecan

raludotatug deruxtecan · Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Raludotatug Deruxtecan, covering 2025-10-14 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) [Phase 1, Phase 2]